Cargando…

Global Pharmacogenomics: Distribution of CYP3A5 Polymorphisms and Phenotypes in the Brazilian Population

The influence of self-reported “race/color”, geographical origin and genetic ancestry on the distribution of three functional CYP3A5 polymorphisms, their imputed haplotypes and inferred phenotypes was examined in 909 healthy, adult Brazilians, self-identified as White, Brown or Black (“race/color” c...

Descripción completa

Detalles Bibliográficos
Autores principales: Suarez-Kurtz, Guilherme, Vargens, Daniela D., Santoro, Ana Beatriz, Hutz, Mara H., de Moraes, Maria Elisabete, Pena, Sérgio D. J., Ribeiro-dos-Santos, Ândrea, Romano-Silva, Marco A., Struchiner, Claudio José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888384/
https://www.ncbi.nlm.nih.gov/pubmed/24427273
http://dx.doi.org/10.1371/journal.pone.0083472
_version_ 1782299048183595008
author Suarez-Kurtz, Guilherme
Vargens, Daniela D.
Santoro, Ana Beatriz
Hutz, Mara H.
de Moraes, Maria Elisabete
Pena, Sérgio D. J.
Ribeiro-dos-Santos, Ândrea
Romano-Silva, Marco A.
Struchiner, Claudio José
author_facet Suarez-Kurtz, Guilherme
Vargens, Daniela D.
Santoro, Ana Beatriz
Hutz, Mara H.
de Moraes, Maria Elisabete
Pena, Sérgio D. J.
Ribeiro-dos-Santos, Ândrea
Romano-Silva, Marco A.
Struchiner, Claudio José
author_sort Suarez-Kurtz, Guilherme
collection PubMed
description The influence of self-reported “race/color”, geographical origin and genetic ancestry on the distribution of three functional CYP3A5 polymorphisms, their imputed haplotypes and inferred phenotypes was examined in 909 healthy, adult Brazilians, self-identified as White, Brown or Black (“race/color” categories of the Brazilian census). The cohort was genotyped for CYP3A5*3 (rs776746), CYP3A5*6 (rs10264272) and CYP3A5*7 (rs41303343), CYP3A5 haplotypes were imputed and CYP3A5 metabolizer phenotypes were inferred according to the number of defective CYP3A5 alleles. Estimates of the individual proportions of Amerindian, African and European ancestry were available for the entire cohort. Multinomial log-linear regression models were applied to infer the statistical association between the distribution of CYP3A5 alleles, haplotypes and phenotypes (response variables), and self-reported Color, geographical region and ancestry (explanatory variables). We found that Color per se or in combination with geographical region associates significantly with the distribution of CYP3A5 variant alleles and CYP3A5 metabolizer phenotypes, whereas geographical region per se influences the frequency distribution of CYP3A5 variant alleles. The odds of having the default CYP3A5*3 allele and the poor metabolizer phenotype increases continuously with the increase of European ancestry and decrease of African ancestry. The opposite trend is observed in relation to CYP3A5*6, CYP3A5*7, the default CYP3A5*1 allele, and both the extensive and intermediate phenotypes. No significant effect of Amerindian ancestry on the distribution of CYP3A5 alleles or phenotypes was observed. In conclusion, this study strongly supports the notion that the intrinsic heterogeneity of the Brazilian population must be acknowledged in the design and interpretation of pharmacogenomic studies, and dealt with as a continuous variable, rather than proportioned in arbitrary categories that do not capture the diversity of the population. The relevance of this work extrapolates the Brazilian borders, and extends to other admixed peoples of the Americas, with ancestral roots in Europe, Africa and the American continent.
format Online
Article
Text
id pubmed-3888384
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38883842014-01-14 Global Pharmacogenomics: Distribution of CYP3A5 Polymorphisms and Phenotypes in the Brazilian Population Suarez-Kurtz, Guilherme Vargens, Daniela D. Santoro, Ana Beatriz Hutz, Mara H. de Moraes, Maria Elisabete Pena, Sérgio D. J. Ribeiro-dos-Santos, Ândrea Romano-Silva, Marco A. Struchiner, Claudio José PLoS One Research Article The influence of self-reported “race/color”, geographical origin and genetic ancestry on the distribution of three functional CYP3A5 polymorphisms, their imputed haplotypes and inferred phenotypes was examined in 909 healthy, adult Brazilians, self-identified as White, Brown or Black (“race/color” categories of the Brazilian census). The cohort was genotyped for CYP3A5*3 (rs776746), CYP3A5*6 (rs10264272) and CYP3A5*7 (rs41303343), CYP3A5 haplotypes were imputed and CYP3A5 metabolizer phenotypes were inferred according to the number of defective CYP3A5 alleles. Estimates of the individual proportions of Amerindian, African and European ancestry were available for the entire cohort. Multinomial log-linear regression models were applied to infer the statistical association between the distribution of CYP3A5 alleles, haplotypes and phenotypes (response variables), and self-reported Color, geographical region and ancestry (explanatory variables). We found that Color per se or in combination with geographical region associates significantly with the distribution of CYP3A5 variant alleles and CYP3A5 metabolizer phenotypes, whereas geographical region per se influences the frequency distribution of CYP3A5 variant alleles. The odds of having the default CYP3A5*3 allele and the poor metabolizer phenotype increases continuously with the increase of European ancestry and decrease of African ancestry. The opposite trend is observed in relation to CYP3A5*6, CYP3A5*7, the default CYP3A5*1 allele, and both the extensive and intermediate phenotypes. No significant effect of Amerindian ancestry on the distribution of CYP3A5 alleles or phenotypes was observed. In conclusion, this study strongly supports the notion that the intrinsic heterogeneity of the Brazilian population must be acknowledged in the design and interpretation of pharmacogenomic studies, and dealt with as a continuous variable, rather than proportioned in arbitrary categories that do not capture the diversity of the population. The relevance of this work extrapolates the Brazilian borders, and extends to other admixed peoples of the Americas, with ancestral roots in Europe, Africa and the American continent. Public Library of Science 2014-01-10 /pmc/articles/PMC3888384/ /pubmed/24427273 http://dx.doi.org/10.1371/journal.pone.0083472 Text en © 2014 Suarez-Kurtz et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Suarez-Kurtz, Guilherme
Vargens, Daniela D.
Santoro, Ana Beatriz
Hutz, Mara H.
de Moraes, Maria Elisabete
Pena, Sérgio D. J.
Ribeiro-dos-Santos, Ândrea
Romano-Silva, Marco A.
Struchiner, Claudio José
Global Pharmacogenomics: Distribution of CYP3A5 Polymorphisms and Phenotypes in the Brazilian Population
title Global Pharmacogenomics: Distribution of CYP3A5 Polymorphisms and Phenotypes in the Brazilian Population
title_full Global Pharmacogenomics: Distribution of CYP3A5 Polymorphisms and Phenotypes in the Brazilian Population
title_fullStr Global Pharmacogenomics: Distribution of CYP3A5 Polymorphisms and Phenotypes in the Brazilian Population
title_full_unstemmed Global Pharmacogenomics: Distribution of CYP3A5 Polymorphisms and Phenotypes in the Brazilian Population
title_short Global Pharmacogenomics: Distribution of CYP3A5 Polymorphisms and Phenotypes in the Brazilian Population
title_sort global pharmacogenomics: distribution of cyp3a5 polymorphisms and phenotypes in the brazilian population
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888384/
https://www.ncbi.nlm.nih.gov/pubmed/24427273
http://dx.doi.org/10.1371/journal.pone.0083472
work_keys_str_mv AT suarezkurtzguilherme globalpharmacogenomicsdistributionofcyp3a5polymorphismsandphenotypesinthebrazilianpopulation
AT vargensdanielad globalpharmacogenomicsdistributionofcyp3a5polymorphismsandphenotypesinthebrazilianpopulation
AT santoroanabeatriz globalpharmacogenomicsdistributionofcyp3a5polymorphismsandphenotypesinthebrazilianpopulation
AT hutzmarah globalpharmacogenomicsdistributionofcyp3a5polymorphismsandphenotypesinthebrazilianpopulation
AT demoraesmariaelisabete globalpharmacogenomicsdistributionofcyp3a5polymorphismsandphenotypesinthebrazilianpopulation
AT penasergiodj globalpharmacogenomicsdistributionofcyp3a5polymorphismsandphenotypesinthebrazilianpopulation
AT ribeirodossantosandrea globalpharmacogenomicsdistributionofcyp3a5polymorphismsandphenotypesinthebrazilianpopulation
AT romanosilvamarcoa globalpharmacogenomicsdistributionofcyp3a5polymorphismsandphenotypesinthebrazilianpopulation
AT struchinerclaudiojose globalpharmacogenomicsdistributionofcyp3a5polymorphismsandphenotypesinthebrazilianpopulation